GENEREX BIOTECHNOLOGY CORP

FREE EMAIL WATCHDOG

Get free email notifications about news in GENEREX BIOTECHNOLOGY CORP.

The service is free and you can unsubscribe at any time.

General | People (83) | Filings (690) | Investment rounds (2) | Annual reports (5) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001059784
IRS Number: 820490211

GENEREX BIOTECHNOLOGY CORP is a publicly traded company

Trading symbol: GNBT

GENEREX BIOTECHNOLOGY CORP is on the market more than 5 years.

News

2017-06-21

Generex Biotechnology Corp (GNBT) Seeing Increased Volatility in Session
Lenox Ledger
Shares of Generex Biotechnology Corp (GNBT) are moving on volatility today -6.25% or $-0.20 from the open. The OTC listed company saw a recent bid of $3.0000 and 493 shares have traded hands in the session.

2017-06-20

Boston Advisors Cut Intel Com (INTC) Position; GENEREX BIOTECHNOLOGY ...
FlintDaily.com
GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) had a decrease of 94.74% in short interest. GNBT's SI was 100 shares in June as released by FINRA.

2017-06-13

Generex Biotechnology Corp (GNBT) Seeing Increased Volatility in Session
Stock Press Daily
Needle moving action has been spotted in Generex Biotechnology Corp (GNBT) as shares are moving today on volatility -8.82% or -0.30 from the open.

2017-06-12

What's in GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) After Decline in ...
Finance News Daily
The stock of GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) registered a decrease of 94.74% in short interest. GNBT's total short interest was 100 shares in June as published by FINRA.

2017-06-12

A Reversal for GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) Is Near. The ...
KL Daily
The stock of GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) registered a decrease of 94.74% in short interest. GNBT's total short interest was 100 shares in June as published by FINRA.

2017-06-08

Mason Street Advisors Boosted Pfizer (PFE) Holding By $306112; GENEREX ...
UtahHerald.com
Generex Biotechnology Corporation is a development-stage company. The company has market cap of $4.79 million. The Firm is engaged in the research and development of drug delivery systems and technologies.

2017-06-08

Mason Street Advisors Boosted Pfizer (PFE) Holding By $306112; GENEREX ...
UtahHerald.com
Generex Biotechnology Corporation is a development-stage company. The company has market cap of $4.79 million. The Firm is engaged in the research and development of drug delivery systems and technologies.

GENEREX BIOTECHNOLOGY CORP address

10102 USA TODAY WAY
MIRAMAR
33025

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

December 1998

Latest known filing

June 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

GENEREX BIOTECHNOLOGY CORP has 690 filings. View GENEREX BIOTECHNOLOGY CORP filings.

Annual Reports

Quarterly Reports

Latest company events

Investment Rounds

GENEREX BIOTECHNOLOGY CORP recieved 2 investments.

People

We have found 83 people related to GENEREX BIOTECHNOLOGY CORP.